Giuseppe Rossi Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

1/2019	The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors.
1/2019	Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment.
1/2018	Nilotinib induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia.
12/2017	Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment.
8/2017	The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Rossi Research Topics

Disease

29	Neoplasms (Cancer) 12/2023 - 05/2003
20	Lymphoma (Lymphomas) 11/2022 - 12/2003
17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 01/2007
12	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2003
10	Multiple Myeloma 01/2021 - 12/2007
10	Pain (Aches) 10/2019 - 12/2007
9	Leukemia 12/2023 - 05/2007
9	Breast Neoplasms (Breast Cancer) 01/2020 - 05/2005
9	Schizophrenia (Dementia Praecox) 01/2017 - 11/2003
8	B-Cell Lymphoma (Lymphoma, B Cell) 02/2024 - 10/2008
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 09/2009
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 06/2005
8	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2005
8	Thyrotoxicosis 09/2014 - 10/2002
7	Mycoses (Diseases, Fungus) 05/2022 - 09/2011
6	COVID-19 12/2023 - 01/2020
6	Residual Neoplasm 01/2022 - 05/2007
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 12/2003
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019 - 09/2013
6	Infections 10/2015 - 07/2002
5	Aneurysmal Bone Cysts 10/2021 - 02/2010
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 08/2017
5	Hodgkin Disease (Hodgkin's Disease) 04/2016 - 09/2002
5	Parkinson Disease (Parkinson's Disease) 10/2013 - 10/2003
5	Thyroiditis 11/2011 - 05/2003
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2022 - 01/2011
4	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021 - 05/2010
4	Heart Failure 01/2019 - 07/2008
4	Fever (Fevers) 01/2018 - 01/2007
4	Myocardial Infarction 01/2018 - 01/2004
4	Acromegaly 11/2016 - 04/2006
4	beta-Thalassemia (Cooley's Anemia) 10/2015 - 07/2009
4	Invasive Fungal Infections 06/2015 - 11/2011
4	Disease Progression 06/2011 - 05/2005
3	Neutropenia 08/2023 - 06/2006
3	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2022 - 11/2013
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 08/2009
3	Philadelphia Chromosome 01/2020 - 08/2010
3	Fibrosis (Cirrhosis) 01/2018 - 11/2013
3	Iron Overload 05/2017 - 01/2011
3	Coronary Stenosis (Coronary Artery Stenosis) 02/2013 - 11/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2013 - 11/2007
3	Hyperthyroidism 01/2010 - 10/2007
3	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 08/2009 - 09/2005
3	HIV Infections (HIV Infection) 09/2005 - 09/2002
2	Lymphopenia (Lymphocytopenia) 12/2023 - 08/2023

Drug/Important Bio-Agent (IBA)

18	Rituximab (Mabthera)FDA Link 02/2024 - 01/2003
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 03/2005
11	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 03/2005
9	Vincristine (Oncovin)FDA LinkGeneric 02/2024 - 08/2010
9	Prednisone (Sone)FDA LinkGeneric 02/2024 - 08/2010
7	Amiodarone (Amiodarona)FDA LinkGeneric 09/2014 - 05/2003
6	Lenalidomide (CC 5013)FDA Link 01/2017 - 02/2010
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2015 - 09/2002
5	HDL CholesterolIBA 02/2013 - 01/2004
5	GlucocorticoidsIBA 11/2011 - 05/2003
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 01/2002
4	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020 - 10/2009
4	Hormones (Hormone)IBA 01/2020 - 03/2014
4	IronIBA 05/2017 - 01/2011
4	Analgesics (Analgesic Drugs)IBA 04/2016 - 04/2011
4	Immunoglobulin M (IgM)IBA 01/2016 - 05/2010
4	Interleukin-2 (IL2)IBA 01/2016 - 05/2005
4	AnthracyclinesIBA 03/2015 - 10/2008
4	Thyroid HormonesIBA 11/2011 - 10/2002
3	Monoclonal AntibodiesIBA 08/2023 - 01/2010
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2019
3	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 12/2020 - 06/2005
3	MicroRNAs (MicroRNA)IBA 05/2019 - 04/2013
3	CytokinesIBA 01/2019 - 11/2003
3	nilotinib FDA Link 01/2019 - 12/2017
3	GadoliniumIBA 01/2018 - 11/2013
3	Bortezomib (Velcade)FDA Link 01/2018 - 12/2007
3	Imatinib Mesylate (Gleevec)FDA Link 08/2017 - 12/2009
3	Antipsychotic Agents (Antipsychotics)IBA 07/2017 - 12/2004
3	Deferoxamine (Desferal)FDA LinkGeneric 05/2017 - 01/2011
3	DeferiproneIBA 05/2017 - 01/2011
3	EnbucrilateIBA 04/2016 - 04/2011
3	Tumor Biomarkers (Tumor Markers)IBA 01/2015 - 12/2010
3	CyanoacrylatesIBA 12/2014 - 02/2010
3	Dopamine Agonists (Dopamine Agonist)IBA 10/2013 - 11/2007
3	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2012 - 10/2002
3	Methotrexate (Mexate)FDA LinkGeneric 10/2009 - 06/2005
2	venetoclaxIBA 01/2024 - 01/2023
2	VaccinesIBA 12/2023 - 01/2019
2	AntibodiesIBA 01/2023 - 12/2008
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2022 - 01/2019
2	Cytostatic AgentsIBA 01/2022 - 10/2010

Therapy/Procedure

55	Therapeutics 01/2023 - 07/2002
38	Drug Therapy (Chemotherapy) 10/2023 - 07/2002
22	Stem Cell Transplantation 10/2023 - 02/2005
9	Radiotherapy 10/2021 - 09/2002
8	Transplantation 10/2023 - 07/2002
7	Immunotherapy 01/2022 - 05/2005
7	Highly Active Antiretroviral Therapy (HAART) 01/2019 - 09/2002
5	Palliative Care (Palliative Therapy) 10/2021 - 02/2011
4	Salvage Therapy 04/2016 - 12/2003
3	Aftercare (After-Treatment) 01/2021 - 01/2006
3	Hematopoietic Stem Cell Transplantation 06/2015 - 02/2005
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 08/2009 - 12/2003